Sebastian Schulz
9PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 28, 2026
EpCAM (CD326) is dispensable for in vitro B cell activation and maintenance of antibody-secreting cells.Shannon R Menzel, Edith Roth, Katharina Pracht
|Jan 02, 2025
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.Ohan Mazigi, David B Langley, Jake Y Henry
|May 25, 2024
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage.Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier
|May 08, 2023
Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage.Inga Nehlmeier, Amy Kempf, Prerna Arora
|Mar 03, 2023
Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5.Markus Hoffmann, Prerna Arora, Inga Nehlmeier
|May 17, 2022
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.Prerna Arora, Amy Kempf, Inga Nehlmeier
Pageof 2
Frequent Collaborators
8 joint publications
Markus Hoffmann
8 joint publications
Stefan Pöhlmann
6 joint publications
Hans-Martin Jäck
6 joint publications
Georg M N Behrens
5 joint publications
Inga Nehlmeier
3 joint publications
Alexandra Dopfer-Jablonka
1 joint publications
Gema Morillas Ramos
1 joint publications
David B Langley
1 joint publications
Deborah L Burnett
1 joint publications
Meghna Sobti
